ENUMERAL BIOMEDICAL
Enumeral Biomedical uses its microengraving (nanotechnology-enabled) process to address opportunities in immunology including therapeutic discovery, immune profiling and personalized medicine.
ENUMERAL BIOMEDICAL
Industry:
Biotechnology Nanotechnology Therapeutics
Founded:
2009-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.enumeral.com
Total Employee:
11+
Status:
Closed
Contact:
2127523633
Email Addresses:
[email protected]
Total Funding:
32.98 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Content Delivery Network Organization Schema IPv6 Google Apps For Business Cloudflare
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
180 Degree Capital
180 Degree Capital investment in Post-IPO Equity - Enumeral Biomedical
Montrose Capital Partners
Montrose Capital Partners investment in Post-IPO Equity - Enumeral Biomedical
Bantam Group
Bantam Group investment in Seed Round - Enumeral Biomedical
Official Site Inspections
http://www.enumeral.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 76.223.54.146
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Enumeral Biomedical"
Neumeral Technologies - Crunchbase Company Profile & Funding
Neumeral Technologies is a software development company that focuses on delivering web-based solutions. The team of technology experts at Neumeral is passionate about creating …See details»
Web, Mobile App, Software Development Company
Neumeral Technologies is a software development company that believes in the power of data and technology to transform business processes. With our collective experience of more than 20 years in the information technology …See details»
enumeral Startup Data | Cold outreach starts with the right data, …
Discover Growing Startups: Discover select startups that have recently raised funding, along with founder details. Actionable Insights: Get startup funding data, open jobs, existing customers, …See details»
enumeral - Crunchbase Company Profile & Funding
We identify organization's challenges, assess how Generative AI can help, and develop custom AI solutions. Lists Featuring This Company. Edit Lists Featuring This Company Section. …See details»
Enumeral - Wikipedia
Enumeral was a Cambridge, Massachusetts-based biotechnology company which developed monoclonal antibody immunotherapies through an 'immunoprofiling' platform that allowed it to scan the human immune microenvironment and identify and validate potential drug candidates. The company filed for Chapter 11 bankruptcy and arranged to sell its assets to Xoma Corporation in January 2018. See details»
Neumeral Technologies | LinkedIn
Neumeral Technologies | 3,441 followers on LinkedIn. Creating Leverage with Technology. | Neumeral Technologies is a software development company based out of Kochi, India. We are …See details»
Neumeral Technologies - Contacts, Employees, Board Members
Neumeral Technologies is a software development firm offering web-based solutions, banking infrastructure, and accounting automation. New. Resources. ... Log In. Experience the new …See details»
Web, Mobile Software Development Services - Neumeral
Neumeral Technologies. Create leverage with systems and technology tools. Company + About Us + Connect on Linkedin; Resources + Engineering Reads + Top Software Development …See details»
Enumeral - Company Profile - Tracxn
Nov 29, 2024 Enumeral - Developing antibodies targeting immune checkpoint proteins such as PD-1, OX40 and Lag-3.. Public Company. Raised a total funding of $5.79M over 7 rounds …See details»
enumeral - LinkedIn
Enumeral | 10 followers on LinkedIn. We Handle Lead Gen. You Close More Deals. | We use custom AI to find and engage your ideal prospects at scale, so you can focus on closing deals, …See details»
Enumeral Biomedical - VentureRadar
"Enumeral is a US biotechnology company which develops monoclonal antibody immunotherapies through an 'immunoprofiling' platform that allows it to scan the human …See details»
Enumeral Biomedical Holdings, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Enumeral Biomedical Holdings, Inc. of Cambridge, MA. Get the latest business insights from Dun & …See details»
Neumeral - GitHub
We are a team of passionate developers delivering quality web, data and automation solutions. - Neumeral. Skip to content. Navigation Menu Toggle navigation. Sign in neumeral. Product …See details»
Top Software Development Company in Kerala | Neumeral …
Neumeral Technologies is a software development company based out of Kochi, India. We are a passionate team of technology experts focused on delivering web, mobile and custom …See details»
Enumeral Biomedical Corp. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Enumeral Biomedical Corp. of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»
enumeral | Devpost
Inspiration. We built enumeral to solve a fundamental problem in B2B sales: getting in front of the right decision-makers efficiently. Too many companies struggle with cold outreach, wasting …See details»
What is Enumeral? Company Culture, Mission, Values
See what employees say it's like to work at Enumeral. Salaries, reviews, and more - all posted by employees working at Enumeral.See details»
Members · People · neumeral - GitHub
We are a team of passionate developers delivering quality web, data and automation solutions. - NeumeralSee details»
enumeral Reviews in 2025 - SourceForge
Q: What kinds of users and organization types does enumeral work with? enumeral works with these users and organization types: Mid Size Business, Small Business, Enterprise, …See details»
Home - Numeral IOT
[vc_custom_heading text="We are an IoT company with the vision of building Africa's largest IoT service platform, which will power utilities, telcos, and direct consumers. Aside from theSee details»